Ingevity Statistics
Total Valuation
Ingevity has a market cap or net worth of $1.77 billion. The enterprise value is $3.24 billion.
| Market Cap | 1.77B |
| Enterprise Value | 3.24B |
Important Dates
The last earnings date was Wednesday, May 1, 2024, after market close.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Ingevity has 36.33 million shares outstanding. The number of shares has decreased by -2.46% in one year.
| Shares Outstanding | 36.33M |
| Shares Change (YoY) | -2.46% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 95.68% |
| Float | 36.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.07 |
| PS Ratio | 1.08 |
| Forward PS | 1.17 |
| PB Ratio | 3.12 |
| P/FCF Ratio | 20.45 |
| PEG Ratio | 2.05 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.88, with an EV/FCF ratio of 37.37.
| EV / Earnings | n/a |
| EV / Sales | 1.98 |
| EV / EBITDA | 35.88 |
| EV / EBIT | n/a |
| EV / FCF | 37.37 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 2.74.
| Current Ratio | 1.90 |
| Quick Ratio | 0.80 |
| Debt / Equity | 2.74 |
| Debt / EBITDA | 17.23 |
| Debt / FCF | 17.94 |
| Interest Coverage | -0.52 |
Financial Efficiency
Return on equity (ROE) is -17.00% and return on invested capital (ROIC) is -0.01%.
| Return on Equity (ROE) | -17.00% |
| Return on Assets (ROA) | -4.20% |
| Return on Capital (ROIC) | -0.01% |
| Revenue Per Employee | $964,471 |
| Profits Per Employee | -$65,941 |
| Employee Count | 1,700 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 3.49 |
Taxes
| Income Tax | -34.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +3.52% in the last 52 weeks. The beta is 1.80, so Ingevity's price volatility has been higher than the market average.
| Beta (1Y) | 1.80 |
| 52-Week Price Change | +3.52% |
| 50-Day Moving Average | 49.27 |
| 200-Day Moving Average | 45.75 |
| Relative Strength Index (RSI) | 43.14 |
| Average Volume (30 Days) | 214,088 |
Short Selling Information
The latest short interest is 734,500, so 2.02% of the outstanding shares have been sold short.
| Short Interest | 734,500 |
| Short Previous Month | 684,517 |
| Short % of Shares Out | 2.02% |
| Short % of Float | 2.04% |
| Short Ratio (days to cover) | 3.27 |
Income Statement
In the last 12 months, Ingevity had revenue of $1.64 billion and -$112.10 million in losses. Loss per share was -$3.06.
| Revenue | 1.64B |
| Gross Profit | 441.20M |
| Operating Income | -300,000 |
| Pretax Income | -146.10M |
| Net Income | -112.10M |
| EBITDA | 90.40M |
| EBIT | -50.10M |
| Loss Per Share | -$3.06 |
Balance Sheet
The company has $88.50 million in cash and $1.56 billion in debt, giving a net cash position of -$1.47 billion or -$40.43 per share.
| Cash & Cash Equivalents | 88.50M |
| Total Debt | 1.56B |
| Net Cash | -1.47B |
| Net Cash Per Share | -$40.43 |
| Equity / Book Value | 568.20M |
| Book Value Per Share | 15.64 |
| Working Capital | 317.50M |
Cash Flow
In the last 12 months, operating cash flow was $187.80 million and capital expenditures -$101.00 million, giving a free cash flow of $86.80 million.
| Operating Cash Flow | 187.80M |
| Capital Expenditures | -101.00M |
| Free Cash Flow | 86.80M |
| FCF Per Share | $2.40 |
Margins
Gross margin is 26.91%, with operating and profit margins of -0.02% and -6.84%.
| Gross Margin | 26.91% |
| Operating Margin | -0.02% |
| Pretax Margin | -8.91% |
| Profit Margin | -6.84% |
| EBITDA Margin | 5.51% |
| EBIT Margin | -3.06% |
| FCF Margin | 5.29% |
Dividends & Yields
Ingevity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 2.46% |
| Shareholder Yield | 2.46% |
| Earnings Yield | -6.32% |
| FCF Yield | 4.89% |
Analyst Forecast
The average price target for Ingevity is $56.20, which is 15.05% higher than the current price. The consensus rating is "Buy".
| Price Target | $56.20 |
| Price Target Difference | 15.05% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Ingevity has an Altman Z-Score of 1.77 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.77 |
| Piotroski F-Score | 4 |